Rifafour is a fixed-dose combination of the following four active TB drugs:
Rifampicin 150 mg
lsoniazid 75 mg
Pyrazinamide 400 mg
Ethambutol HCI 275 mg
This regimen is considered the standard approved treatment for drug-sensitive Tuberculosis.
Compound
Rifafour
Regimen Associations
Trial Associations